$TXMD
TherapeuticsMD, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$2.14
▼-1.63%-$0.036
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is TXMD down today? It is at $2.14 (-1.63%). See the catalyst behind the move, real-time alerts the moment TXMD spikes, and full due diligence on TXMD — key stats, earnings, dilution and insider activity. Free.
Be first to know when $TXMD makes an unusual move. Create a free account to track $TXMD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TXMD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TXMD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Thompson Tommy G Director | Bought (open market) | +8K 0.07% of company | added 57% | 23K | $14K at $1.67 | Dec 23, 25 |
Walker Marlan D Officer | Bought (open market) | +490 | added 0.7% | 74K | $490 at $1.00 | Apr 14, 25 |
Thompson Tommy G Director | Bought (open market) | +325 | added 2.2% | 15K | $325 at $1.00 | Apr 14, 25 |
Walker Marlan D Officer | Bought (open market) | +1K 0.01% of company | added 1.6% | 73K | $1K at $0.860 | Apr 10, 25 |
Walker Marlan D Officer | Bought (open market) | +1K | added 1.6% | 72K | $988 at $0.870 | Apr 9, 25 |
Walker Marlan D Officer | Other | 8K 0.07% of company | added 13% | 71K | n/a | Feb 18, 25 |
Thompson Tommy G Director | Other | 9K 0.07% of company | added 100% | 14K | n/a | Feb 18, 25 |
Naughton Gail K Director | Other | 9K 0.07% of company | n/a | 9K | n/a | Feb 18, 25 |
Collins Cooper C. Director | Other | 9K 0.07% of company | added 16% | 61K | n/a | Feb 18, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on TXMD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TXMD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TXMD last traded at $2.14, down 1.63% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
TherapeuticsMD, Inc. (TXMD) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TXMD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TXMD 0 times in the last 30 days.
TXMD (TherapeuticsMD, Inc.) trades on XNAS, with a market cap of about $25M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TXMD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TXMD discussion
Sign in to ask a question or join the discussion.